21
TITLE: Discordant predictions of residual activity could impact dolutegravir prescription upon raltegravir failure  Full Text
AUTHORS: Kristof Theys; Ana Abecasis; Pieter Libin; Perpeitua Gomes; Joaquim Cabanas; Ricardo J Camacho; Kristel Van Laethem;
PUBLISHED: 2015, SOURCE: JOURNAL OF CLINICAL VIROLOGY, VOLUME: 70
INDEXED IN: Scopus WOS CrossRef: 6
22
TITLE: Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1-6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance  Full Text
AUTHORS: Lize Cuypers; Guangdi D Li; Pieter Libin; Supinya Piampongsant; Anne Mieke Vandamme; Kristof Theys;
PUBLISHED: 2015, SOURCE: VIRUSES-BASEL, VOLUME: 7, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
23
TITLE: CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba
AUTHORS: Vivian Kouri; Ricardo Khouri; Yoan Aleman; Yeissel Abrahantes; Jurgen Vercauteren; Andrea Clemencia Pineda Pena; Kristof Theys; Sarah Megens; Michel Moutschen; Nico Pfeifer; Johan Van Weyenbergh; Ana B Perez; Jorge Perez; Lissette Perez; Kristel Van Laethem; Anne Mieke Vandamme;
PUBLISHED: 2015, SOURCE: EBIOMEDICINE, VOLUME: 2, ISSUE: 3
INDEXED IN: WOS CrossRef
24
TITLE: Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals
AUTHORS: Raf Winand; Kristof Theys; Monica Eusebio; Jan Aerts; Ricardo J Camacho; Perpetua Gomes; Marc A Suchard; Anne Mieke Vandamme; Ana B Abecasis;
PUBLISHED: 2015, SOURCE: AIDS, VOLUME: 29, ISSUE: 15
INDEXED IN: WOS CrossRef: 16
25
TITLE: Characterization of amino acids Arg, Ser and Thr at position 70 within HIV-1 reverse transcriptase
AUTHORS: Megens, S; De Wit, S; Bernatchez, J; Dekeersmaeker, N; Vinken, L; Covens, K; Theys, K; Camacho, RJ; M Vandamme; Goette, M; Van Laethem, K;
PUBLISHED: 2014, SOURCE: ACTA CLINICA BELGICA, VOLUME: 69, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef
26
TITLE: HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir
AUTHORS: Theys, K; Vercauteren, J; Snoeck, J; Zazzi, M; Camacho, RJ; Torti, C; Schuelter, E; Clotet, B; Soennerborg, A; De Luca, A; Grossman, Z; Struck, D; Vandamme, AM ; Abecasis, AB;
PUBLISHED: 2013, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 57, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
27
TITLE: Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir
AUTHORS: Theys, K; Snoeck, J; Vercauteren, J; Abecasis, AB ; Vandamme, AM ; Camacho, RJ; Mansinho, K; Miranda, AC; Aldir, I; Ventura, F; Nina, J; Borges, F; Valadas, E; Doroana, M; Antunes, F; Aleixo, MJ; Aguas, MJ; Botas, J; Branco, T; Vera, J; Pinto, IV; Sa, J; Duque, L; Diniz, A; Mineiro, A; Gomes, F; Santos, C; Faria, D; Fonseca, P; Proenca, P; Tavares, L; Guerreiro, C; Narciso, J; Faria, T; Teofilo, E; Pinheiro, S; Germano, I; Caixas, U; Faria, N; Reis, AP; Jesus, MB; Amaro, G; Roxo, F; Abreu, R; Neves, I; ...More
PUBLISHED: 2013, SOURCE: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, VOLUME: 68, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
28
TITLE: HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics  Full Text
AUTHORS: Ana B Abecasis ; Annemarie M J Wensing; Dimitris Paraskevis; Jurgen Vercauteren; Kristof Theys; David Van M C V de Vijver; Jan Albert; Birgitta Asjo; Claudia Balotta; Danail Beshkov; Ricardo J Camacho; Bonaventura Clotet; Cillian De Gascun; Algis Griskevicius; Zehava Grossman; Osamah Hamouda; Andrzej Horban; Tatjana Kolupajeva; Klaus Korn; Leon G Kostrikis; Claudia Kuecherer; Kirsi Liitsola; Marek Linka; Claus Nielsen; Dan Otelea; Roger Paredes; Mario Poljak; Elisabeth Puchhammer Stoeckl; Jean Claude Schmit; Anders Sonnerborg; Danika Stanekova; Maja Stanojevic; Daniel Struck; Charles A B Boucher; Anne Mieke Vandamme ; ...More
PUBLISHED: 2013, SOURCE: RETROVIROLOGY, VOLUME: 10, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
29
TITLE: The demise of multidrug-resistant HIV-1: the national time trend in Portugal
AUTHORS: Vercauteren, J; Theys, K; Carvalho, AP; Valadas, E ; Duque, LM; Teofilo, E; Faria, T; Faria, D; Vera, J; Aguas, MJ; Peres, S; Mansinho, K; A.-M Vandamme ; Camacho, RJ; Mansinho, K; Claudia Miranda, A; Aldir, I; Ventura, F; Nina, J; Borges, F; Valadas, E; Doroana, M; Antunes, F; Joao Aleixo, M; Joao Aguas, M; Botas, J; Branco, T; Vera, J; Vaz Pinto, I; Pocas, J; Sa, J; Duque, L; Diniz, A; Mineiro, A; Gomes, F; Santos, C; Faria, D; Fonseca, P; Proenca, P; Tavares, L; Guerreiro, C; Narciso, J; Faria, T; Teofilo, E; Pinheiro, S; Germano, I; Caixas, U; Faria, N; Paula Reis, A; Bentes Jesus, M; Amaro, G; Roxo, F; Abreu, R; Neves, I; ...More
PUBLISHED: 2013, SOURCE: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, VOLUME: 68, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
30
TITLE: HIV-1 drug resistance: where do polymorphisms fit in?
AUTHORS: Kristof Theys; Ana B Abecasis ; Anne Mieke Vandamme ;
PUBLISHED: 2013, SOURCE: FUTURE MICROBIOLOGY, VOLUME: 8, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
Página 3 de 5. Total de resultados: 43.